Lexaria Bioscience Cash Flow Statement 2018-2024 | LEXX

Fifteen years of historical annual cash flow statements for Lexaria Bioscience (LEXX).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021202020192018
$-6.71$-7.38$-4.19$-4.08$-4.16$-6.61
$0.15$0.10$0.15$0.15$0.06$0.00
$0.54$2.75$-0.01$1.51$1.01$4.46
$0.69$2.86$0.13$1.66$1.07$4.46
$0.03$-0.14$0.19$-0.09$-0.14$-0.25
$0.04$0.00$0.10$0.00$-0.05$-0.03
$0$0$0$0$0$0
$-0.01$-0.26$-0.23$-0.06$0.17$-0.10
$0.14$-0.35$0.06$-0.19$0.08$-0.37
$-5.88$-4.88$-3.99$-2.62$-3.01$-2.52
$-0.03$-0.05$0.27$0$-0.65$0
$-0.14$-0.13$-0.08$-0.03$-0.12$-0.09
$0$0$0$0$0$0
$0$0$0$0.01$0$0
$0$0$0$0$0$-0.07
$0$0$0$0.01$0$-0.07
$0$0$0$0$0$0
$-0.17$-0.18$0.19$-0.03$-0.77$-0.16
$0$-0.04$-0.07$-0.01$0$0
$0$0$0$0$0$0
$0$-0.04$-0.07$-0.01$0$0
$1.59$0$13.49$2.67$2.33$1.87
$1.59$0$13.49$2.67$2.33$1.87
$0$0$0$0$0$0
$0$0$0$0$1.00$0
$1.59$-0.04$13.42$2.65$3.33$1.87
$-4.46$-5.10$9.62$0.01$-0.44$-0.81
$0.17$1.95$0.50$1.24$0.86$3.38
$0$0$0$0$0$0